Salvage TherapyTreatment OutcomeRecurrenceRemission InductionAntineoplastic Combined Chemotherapy ProtocolsHodgkin DiseaseTransplantation, AutologousAnemia, RefractoryRefractory Period, ElectrophysiologicalHematopoietic Stem Cell TransplantationCytarabineAntibodies, Monoclonal, Murine-DerivedCyclophosphamideDrug Resistance, NeoplasmLymphoma, Non-HodgkinEtoposideThiotepaMelphalanMultiple MyelomaAntineoplastic AgentsTransplantation ConditioningCombined Modality TherapyTransplantation, HomologousAntibodies, MonoclonalAnemia, Refractory, with Excess of BlastsDrug Administration ScheduleVincristineDisease-Free SurvivalLymphoma, FollicularSurvival RateDrug ResistancePrednisonePrognosisSurvival AnalysisNeoplasm Recurrence, LocalMethotrexateRetrospective StudiesImmunosuppressive AgentsLymphoma, Large B-Cell, DiffuseBone Marrow TransplantationLeukemia, Myeloid, AcuteStem Cell TransplantationDoxorubicinGraft vs Host DiseaseFollow-Up StudiesTime FactorsClinical Trials as TopicDisease ProgressionThalidomideInfusions, IntravenousAnticonvulsantsTreatment FailureRefractory Period, PsychologicalBoronic AcidsEpilepsyPyrazinesMaximum Tolerated DoseDose-Response Relationship, DrugDrug EvaluationAnemia, SideroblasticPain, IntractableArabinonucleosidesEpilepsies, PartialVidarabineHeart Conduction SystemPiracetamDrug Therapy, CombinationMyelodysplastic SyndromesAtrioventricular NodeAnti-Arrhythmia AgentsCardiac Pacing, ArtificialThrombocytopeniaNeoplasmsAscitesRetreatmentVagus Nerve StimulationAtrial FibrillationStatus EpilepticusNitrogen Mustard CompoundsHeart AtriaMitoxantroneDexamethasoneIfosfamideAdministration, OralImmunologic FactorsElectrocardiographyMineral FibersProspective StudiesNauseaPurpura, Thrombocytopenic, IdiopathicNeutropeniaLeukemia, Lymphocytic, Chronic, B-CellPeritoneovenous ShuntElectric Stimulation TherapyAntibodies, Monoclonal, HumanizedTopotecanEpilepsy, Temporal LobeChronic DiseaseAntigens, CD20Epilepsy, Complex Partial